Disclosure Panels Details Page
Melanoma Panel - Disclosures as of 11/22/2022
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Mark Albertini MD | Apeiron Biologics, Vienna, Austria Array BioPharma Inc, Boulder, CO Bristol-Myers Squibb Company Merck & Co., Inc. Nektar Therapeutics |
None | None | None | ✔ |
| Christopher Barker MD | Alpha Tau Medical Amgen Inc. Elekta EMD Serono Merck & Co., Inc. Physical Sciences Incorporated (through subcontracted funds from NIH) Regeneron Pharmactcls |
Castle Biosciences Regeneron Pharmaceuticals, Inc. |
None | None | ✔ |
| Joel Baumgartner MD | None | None | None | None | ✔ |
| Marian Birkeland PhD | None | None | None | None | - |
| Genevieve Boland MD, PhD | InterVenn Biosciences Olink Proteomics Palleon Pharmaceuticals Takeda Pharmaceuticals North America, Inc. Teiko |
Ankyra Therapeutics Instil Bio InterVenn Biosciences Iovance pharmaceuticals Merck & Co., Inc. Nektar Therapeutics Novartis Pharmaceuticals Corporation |
Novartis Pharmaceuticals Corporation | Ankyra | - |
| Bartosz Chmielowski MD, PhD | Adagene Advenchen Laboratories Ascentage Atreca Bristol-Myers Squibb Company Compugen Daiichi- Sankyo Co. Delcath IDEAYA Biosciences Idera Immunocore Infinity Pharmaceuticals, Inc InstilBio Iovance Karyopharm Therapeutics Macrogenics Merck & Co., Inc. Nektar Therapeutics Novartis Pharmaceuticals Corporation PACT Pharma RAPT Therapeutics Replimune Xencor |
Delcath Expert Witness InstilBio Nektar Therapeutics Novartis Pharmaceuticals Corporation |
None | None | - |
| Dominick DiMaio MD | None | None | None | None | ✔ |
| Roxana Dronca MD | Alkermes Bristol-Myers Squibb Company Emerson Collective Phosplatin Therapeutics Regeneron Pharmactcls Sorento Therapeutics |
Bristol-Myers Squibb Company Eisai Inc. Elsevier, Inc. EMD Serono Genzyme Corporation Immunovaccine Technologies Natera |
Bristol-Myers Squibb Company Eisai Inc. Elsevier, Inc. EMD Serono Genzyme Corporation Immunovaccine technologies Natera |
None | ✔ |
| Ryan Fields MD | None | None | None | None | ✔ |
| Martin Fleming MD, FACS | Castle Biosciences | Castle Biosciences | None | None | ✔ |
| Anjela Galan MD | None | None | None | None | ✔ |
| Brian Gastman MD | Alkermes InstilBio Merck NIT |
BMS InstilBio Iovance Merck |
Castle Biosciences Quest Imaging |
Cutaneous Malignancies: A Surgical Perspective 1st Edition | ✔ |
| Kristina Gregory MSN, RN, OCN | None | None | None | None | - |
| Samantha Guild JD | None | Melanoma Research Program (CDMRP) State of Texas |
None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Ashley Holder MD | None | None | None | None | ✔ |
| John Hyngstrom MD | Amgen Inc. Bristol-Myers Squibb Company Checkmate Iovance pharmaceuticals Lokon Merck & Co., Inc. Morphogenesis Naterra National Cancer Institute Oncosec Philogen |
None | None | None | ✔ |
| Douglas Johnson MD, MSCI | None | None | Bristol-Myers Squibb Company Catalyst Biopharma Iovance Mallinckrodt Merck & Co., Inc. Mosaic ImmunoEngineering Novartis Pharmaceuticals Corporation Pfizer Inc. Teiko |
Patent for MHC-II as a biomarker for immunotherapy response|Patient for abatacept or belatacept as treatment for refractory irAEs | ✔ |
| Madeline Joyce BSN, RN, OCN | None | None | None | None | - |
| Giorgos Karakousis MD | Merck & Co., Inc. | Merck & Co., Inc. | None | None | ✔ |
| Ann Karosas RPh, BCOP | None | None | None | None | - |
| Kari Kendra MD, PhD | Amgen Inc. checkmate pharmaceuticals Istari oncology Karyopharm Therapeutics medspace Merck & Co., Inc. National Institute on Aging Pfizer Inc. Regeneron Pharmaceuticals, Inc. |
None | None | None | ✔ |
| Maija Kiuru MD, PhD | CalDerm NanoString Technologies, Inc. |
None | None | None | ✔ |
| Rashmi Kumar PhD | None | None | None | None | - |
| Julie Lange MD, ScM | None | None | None | None | ✔ |
| Ryan Lanning MD, PhD | None | None | None | None | ✔ |
| Theodore Logan MD, FACP | Abbott Laboratories Abraxis Bioscience, Inc. Acceleron Pharma, Inc. Amgen Inc. Argos Therapeutics AstraZeneca Pharmaceuticals LP AVEO Pharmaceuticals, Inc. Biovex Bristol-Myers Squibb Company Cerulean Pharma Dynavax Technologies Eisai Inc. Eli Lilly and Company EMD Serono GlaxoSmithKline Immatics Iovance pharmaceuticals MacroGenics MedImmune Inc. Merck & Co., Inc. Millennium Pharmaceuticals, Inc. NiKang Therapeutics Novartis Pharmaceuticals Corporation Peloton Therapeutics, Inc. Pfizer Inc. Prometheus Roche Laboratories, Inc. Synta Pharmaceuticals Corp. Threshold Pharmaceuticals TRACON Pharmaceuticals, Inc. |
None | None | None | ✔ |
| Senem Lubin PhD, MBA | None | None | None | None | - |
| Miguel Materin MD | None | Castle Biosciences | None | None | - |
| Lisa McKale | None | None | None | None | - |
| Nicole McMillian MS | None | None | None | None | - |
| Anthony Olszanski MD, RPh | Alkermes Astellas Pharma US, Inc. Bristol-Myers Squibb Company Checkmate Elucida Fate GlaxoSmithKline Glyconex InstilBio Intensity Istari Kadmon Kartos Kezar Kinnate OncoSec SpringBank Sumitomo Dainippon Takeda Pharmaceuticals North America, Inc. |
Bristol-Myers Squibb Company Eisai Inc. InstilBio Merck & Co., Inc. Nektar Therapeutics Novartis Pharmaceuticals Corporation Takeda Pharmaceuticals North America, Inc. |
None | None | ✔ |
| Patrick Ott MD, PhD | Bristol-Myers Squibb Company Genentech, Inc. Merck & Co., Inc. Oncorus Xencor |
Bristol-Myers Squibb Company Evaxion Merck & Co., Inc. Pfizer Inc. Phio |
None | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Merrick Ross MD | Amgen Inc. | Amgen Inc. Merck & Co., Inc. |
Amgen Inc. | None | ✔ |
| April Salama MD | Bristol-Myers Squibb Company Ideaya Immunocore Merck & Co., Inc. Nektar Therapeutics Olatec Regeneron Pharmactcls Replimune Seattle Genetics, Inc. |
Novartis Pharmaceuticals Corporation Pfizer Inc. Regeneron Pharmaceuticals, Inc. |
None | None | ✔ |
| Rohit Sharma MD | None | None | None | None | ✔ |
| Arun Singh MD | None | AURA ISOAID LLC |
Immunocore | AURA | - |
| Joseph Skitzki MD | None | None | None | None | ✔ |
| Emily Smith MD, FAAD | None | None | Gather-Ed | None | ✔ |
| Jeffrey Sosman MD | None | Array Jazz Pharmaceuticals Inc. Nektar Therapeutics Pfizer Inc. |
None | None | - |
| Andrew Stacey MD, MS | None | None | None | None | - |
| Susan Swetter MD | None | None | None | None | ✔ |
| John Thompson MD | None | Mabquest | None | None | ✔ |
| Katy Tsai MD | Bristol-Myers Squibb Company Genentech, Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation Oncosec Pfizer Inc. Replimune |
Bristol-Myers Squibb Company | None | None | ✔ |
| Evan Wuthrick MD | None | None | Alpha Tau Castle Biosciences Viewray |
None | ✔ |
| Yan Xing MD, PhD | None | None | None | None | ✔ |